X4 Pharmaceuticals
XFOR
XFOR
52 hedge funds and large institutions have $40.2M invested in X4 Pharmaceuticals in 2021 Q4 according to their latest regulatory filings, with 13 funds opening new positions, 12 increasing their positions, 14 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less ownership
Funds ownership: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
37% less call options, than puts
Call options by funds: $266K | Put options by funds: $421K
53% less capital invested
Capital invested by funds: $85.7M → $40.2M (-$45.5M)
67% less funds holding in top 10
Funds holding in top 10: 3 → 1 (-2)
Holders
52
Holding in Top 10
1
Calls
$266K
Puts
$421K
Top Buyers
| 1 | +$3.74M | |
| 2 | +$3.62M | |
| 3 | +$1.76M | |
| 4 |
Axa
Paris,
France
|
+$1.29M |
| 5 |
Ensign Peak Advisors
Salt Lake City,
Utah
|
+$339K |
Top Sellers
| 1 | -$4.26M | |
| 2 | -$2.97M | |
| 3 | -$2.67M | |
| 4 |
SCM
Sio Capital Management
New York
|
-$1.21M |
| 5 |
IC
Ikarian Capital
Dallas,
Texas
|
-$631K |